Expansion Therapeutics, Inc. — Form D
Expansion Therapeutics, Inc. of Jupiter, FL, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-03. The offering totals $55.3M, of which $25.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-01-03
- Form: D
- Accession: 0001704086-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $55.3M
- Amount sold: $25.3M
- Remaining: $30.0M
- Investors: 8
- Date of first sale: 2017-12-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-302251
Issuer
- Name: Expansion Therapeutics, Inc.
- CIK: 0001691275
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 555 Heritage Drive, Suite 150, Jupiter, FL, 33458
- Phone: 561-898-1515
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Matthew Disney, Ph.D. | Director | Del Mar, CA |
| Kevin Forrest, Ph.D. | Director | San Diego, CA |
| Jason Hafler, Ph.D. | Director | Bridgewater, NJ |
| Yujiro Hata, M.B.A. | Director | Del Mar, CA |
| Campbell Murray, M.B.B.S., M.B.A. | Director | Cambridge, MA |
| Kevin Forrest, Ph.D. | Executive Officer | San Diego, CA |
| Beth Seidenberg, M.D. | Director | SOUTH SAN FRANCISCO, CA |
| Jason Hafler | Director | South San Francisco, CA |
| Matthew Disney | Director | JUPITER, FL |
| Yujiro Hata | Director | Monrovia, CA |
| Renato Skerlj, Ph.D. | Director | Jupiter, FL |
| Renato Skerlj, Ph.D. | Executive Officer | Jupiter, FL |
| Laura Tadvalkar, Ph.D. | Director | Jupiter, FL |
| Andy Phillips, Ph.D. | Director | Jupiter, FL |
| Scott Rocklage, Ph.D. | Director | Jupiter, FL |
| Scott Rocklage | Director | Menlo Park, CA |
| Scott Rocklage | Executive Officer | Menlo Park, CA |
| Paul Stone | Executive Officer | Portland, OR |
| Kevin Forrest | Director | San Diego, CA |
| Kevin Forrest | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More